Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$820M |
| 2 |
Microsoft
MSFT
|
+$811M |
| 3 |
McDonald's
MCD
|
+$804M |
| 4 |
Coca-Cola
KO
|
+$655M |
| 5 |
Amazon
AMZN
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.1B |
| 3 |
Strategy Inc
MSTR
|
+$564M |
| 4 |
Kroger
KR
|
+$558M |
| 5 |
Danaher
DHR
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.33% |
| 2 | Healthcare | 3.23% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 2.55% |
| 5 | Industrials | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5601
ImmunityBio
IBRX
$8.43B
| $2.08M | ﹤0.01% |
786,225
+307,902
| +64% | +$828K |
|
5602
ATN International
ATNI
$483M
| $2.07M | ﹤0.01% |
127,661
-27,091
| -18% | -$441K |
|
|
VMEO
5603
DELISTED
Vimeo
VMEO
| $2.07M | ﹤0.01% |
512,985
+218,878
| +74% | +$1.01M |
|
5604
CALL
Americold
COLD
$4.32B
| $2.07M | ﹤0.01% |
124,600
+95,100
| +322% | +$1.72M |
|
5605
Tyra Biosciences
TYRA
$1.54B
| $2.07M | ﹤0.01% |
216,136
+119,854
| +124% | +$1.14M |
|
|
GPGI
5606
CALL
GPGI Inc
GPGI
$3.74B
| $2.07M | ﹤0.01% |
146,800
+46,300
| +46% | +$568K |
|
|
CSW
5607
CALL
CSW Industrials
CSW
$5.26B
| $2.07M | ﹤0.01% |
7,200
+900
| +14% | +$272K |
|
|
MREO
5608
Mereo BioPharma
MREO
$46.8M
| $2.06M | ﹤0.01% |
760,659
+417,006
| +121% | +$1.01M |
|
5609
Fidelity Value Factor ETF
FVAL
$1.36B
| $2.06M | ﹤0.01% |
32,237
-10,876
| -25% | -$651K |
|
5610
CALL
Equitable Holdings
EQH
$13.4B
| $2.06M | ﹤0.01% |
36,700
+1,900
| +5% | +$97.7K |
|
|
BCAX
5611
Bicara Therapeutics
BCAX
$1.61B
| $2.06M | ﹤0.01% |
+221,516
| New | +$2.64M |
|
5612
CALL
Roundhill N-100 0DTE Covered Call Strategy ETF
QDTE
$942M
| $2.06M | ﹤0.01% |
57,900
+42,900
| +286% | +$1.42M |
|
5613
CALL
Travere Therapeutics
TVTX
$6.08B
| $2.05M | ﹤0.01% |
138,800
+14,300
| +11% | +$237K |
|
5614
PUT
Kodak
KODK
$949M
| $2.05M | ﹤0.01% |
363,300
-110,000
| -23% | -$661K |
|
5615
Northern Trust Ultra-Short Fixed Income ETF
RAVI
$1.5B
| $2.05M | ﹤0.01% |
27,152
-51,339
| -65% | -$3.86M |
|
5616
Global X MLP ETF
MLPA
$2.34B
| $2.05M | ﹤0.01% |
40,764
+38,542
| +1,735% | +$1.92M |
|
5617
CALL
Ituran Location and Control
ITRN
$1B
| $2.04M | ﹤0.01% |
52,800
+41,700
| +376% | +$1.5M |
|
5618
PUT
Sensata Technologies
ST
$6.12B
| $2.04M | ﹤0.01% |
67,900
-40,900
| -38% | -$1M |
|
5619
iShares Russell 2500 ETF
SMMD
$3.78B
| $2.04M | ﹤0.01% |
30,139
+8,206
| +37% | +$520K |
|
5620
CALL
Xponential Fitness
XPOF
$213M
| $2.04M | ﹤0.01% |
272,600
-53,300
| -16% | -$442K |
|
5621
B&G Foods
BGS
$273M
| $2.04M | ﹤0.01% |
482,617
+283,183
| +142% | +$1.48M |
|
|
AGNT
5622
AGNT Inc
AGNT
$760M
| $2.04M | ﹤0.01% |
224,273
+133,786
| +148% | +$1.17M |
|
5623
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$817M
| $2.04M | ﹤0.01% |
69,916
+59,695
| +584% | +$1.7M |
|
5624
Arcutis Biotherapeutics
ARQT
$3.14B
| $2.04M | ﹤0.01% |
145,493
-164,582
| -53% | -$2.31M |
|
5625
PUT
Vanguard Morningstar Small-Cap ETF
VB
$81.9B
| $2.04M | ﹤0.01% |
8,600
-5,800
| -40% | -$1.29M |
|
Similar funds
Citadel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Citadel Advisors held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Citadel Advisors withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Walmart Inc worth $401M.
- Citadel Advisors's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
- Citadel Advisors added most to NVIDIA in Q2 2025, an estimated $820M increase.
- Citadel Advisors's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
- Citadel Advisors fully exited Kroger in Q2 2025, selling an estimated $558M.
- Citadel Advisors's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
- Citadel Advisors opened 1,459 new positions and closed 3,524 in Q2 2025.
- Citadel Advisors's portfolio value rose 9.2% quarter-over-quarter to $576B.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.